Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ebeid

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1997
Paroxetine-induced choreaG C Fox, S Ebeid, G Vincenti
Clinical Therapeutics|December 20, 2024
Population Pharmacokinetics of Ledipasvir/Sofosbuvir in Pediatric Patients: Impact of Acute Lymphoblastic LeukemiaAya M AbdelMagid, Maggie M Abbassi, Fatma S Ebeid, et al.
Clinical Therapeutics|November 4, 2023
Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancies: A Pharmacokinetic StudyAya M AbdelMagid, Maggie M Abbassi, Fatma S Ebeid, et al.
Hematology/Oncology and Stem Cell Therapy|December 15, 2010
Cardiac events and cardiac T2* in Egyptian children and young adults with beta-thalassemia major taking deferoxamineMohsen S Elalfy, Iman A Abdin, Usama R El Safy, et al.
Clinics and Research in Hepatology and Gastroenterology|June 29, 2021
Beta-thalassemia major alters sofosbuvir/ledipasvir exposure in Hepatitis C virus infected adolescent patientsIman A El-Baraky, Maggie M Abbassi, Fatma S Ebeid, et al.
Journal of Pediatric Hematology/Oncology|December 5, 2017
Neuropilin-1/CD304 Expression by Flow Cytometry in Pediatric Precursor B-Acute Lymphoblastic Leukemia: A Minimal Residual Disease and Potential Prognostic MarkerHala M Abaza, Mervat A A Alfeky, Deena S Eissa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 6, 2025
Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in Young Children With Chronic HCV InfectionAhmed N Farrag, Maggie M Abbassi, Nirmeen A Sabry, et al.
Archives of Virology|January 25, 2021
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized studyHany M Dabbous, Sherief Abd-Elsalam, Manal H El-Sayed, et al.
Archives of Virology|November 23, 2021
Retraction Note to: Efficacy of favipiravir in COVID‑19 treatment: a multi‑center randomized studyHany M Dabbous, Sherief Abd-Elsalam, Manal H El-Sayed, et al.
Scientific Reports|September 19, 2021
Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trialHany M Dabbous, Manal H El-Sayed, Gihan El Assal, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1997
Paroxetine-induced choreaG C Fox, S Ebeid, G Vincenti
Clinical Therapeutics|December 20, 2024
Population Pharmacokinetics of Ledipasvir/Sofosbuvir in Pediatric Patients: Impact of Acute Lymphoblastic LeukemiaAya M AbdelMagid, Maggie M Abbassi, Fatma S Ebeid, et al.
Clinical Therapeutics|November 4, 2023
Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancies: A Pharmacokinetic StudyAya M AbdelMagid, Maggie M Abbassi, Fatma S Ebeid, et al.
Hematology/Oncology and Stem Cell Therapy|December 15, 2010
Cardiac events and cardiac T2* in Egyptian children and young adults with beta-thalassemia major taking deferoxamineMohsen S Elalfy, Iman A Abdin, Usama R El Safy, et al.
Clinics and Research in Hepatology and Gastroenterology|June 29, 2021
Beta-thalassemia major alters sofosbuvir/ledipasvir exposure in Hepatitis C virus infected adolescent patientsIman A El-Baraky, Maggie M Abbassi, Fatma S Ebeid, et al.
Journal of Pediatric Hematology/Oncology|December 5, 2017
Neuropilin-1/CD304 Expression by Flow Cytometry in Pediatric Precursor B-Acute Lymphoblastic Leukemia: A Minimal Residual Disease and Potential Prognostic MarkerHala M Abaza, Mervat A A Alfeky, Deena S Eissa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 6, 2025
Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in Young Children With Chronic HCV InfectionAhmed N Farrag, Maggie M Abbassi, Nirmeen A Sabry, et al.
Archives of Virology|January 25, 2021
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized studyHany M Dabbous, Sherief Abd-Elsalam, Manal H El-Sayed, et al.
Archives of Virology|November 23, 2021
Retraction Note to: Efficacy of favipiravir in COVID‑19 treatment: a multi‑center randomized studyHany M Dabbous, Sherief Abd-Elsalam, Manal H El-Sayed, et al.
Scientific Reports|September 19, 2021
Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trialHany M Dabbous, Manal H El-Sayed, Gihan El Assal, et al.
Pageof 2